NEWS & More

THE LATEST NEWS AND EVENTS

Prediction of Amyloid PET Positivity from Blood-Based Biomarkers, Proteomics, and Clinical Data Discovered through Aitia’s Digital Twins to be Presented at CTAD 2023

Leveraging AI in Healthcare and Life Sciences Discussion: Join our CEO, Colin Hill at the Sixth Annual International IP Summit

Aitia and Pancreatic Cancer Action Network Partner to Transform De-Identified Multi-Omic Patient Data into Digital Twins to Drive New Discoveries and Improve Patient Outcomes

A Digital Boost for Pharmaceutical R&D: Join our CEO, Colin Hill at the Orion Day in Finland

Accelerating Drug Target Identification and Validation with AI and Digital Twins: Join our CBO, Joseph Donahue at BioTechX Europe 2023

CEO and Investor Roundtable Discussion: Join our CEO, Colin Hill at BioCentury East-West Pharma Summit 2023

Aitia Appoints Drug R&D Executive Jean-Michel Gries as President & Chief Operating Officer

Driving Research in Pancreatic Cancer: Join our CEO, Colin Hill on the PanCAN Scientific Summit 2023

Fireside Chat: Join our CEO, Colin Hill on the Longwood Healthcare Leaders Fall Conference

Webinar | From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease